skip to main content

A 28-Year-Old Male Patient With Right Heart Failure Due To Pulmonary Hypertension

Yuri Savitri  -  Department of Cardiology, Cut Meutia General Hospital, Aceh Utara, Indonesia
Wina Yunida M Siregar orcid  -  Undergraduate Program, Faculty of Medicine, Universitas Malikussaleh, Lhokseumawe, Aceh, Indonesia
Viola Septina orcid  -  Undergraduate Program, Faculty of Medicine, Universitas Malikussaleh, Lhokseumawe, Aceh, Indonesia
M Fathul Arif orcid  -  Undergraduate Program, Faculty of Medicine, Universitas Malikussaleh, Lhokseumawe, Aceh, Indonesia
Arini Nashirah orcid  -  , Indonesia
*Narisha Amelia Putri orcid  -  Undergraduate Program, Faculty of Medicine, Universitas Malikussaleh, Lhokseumawe, Aceh, Indonesia

Citation Format:
Abstract
Abstract Right Heart Failure (RHF) as a rapidly progressive syndrome with systemic congestion in the setting of impaired RV filling and/or decreased RV outflow output. A 28-year-old male patient, a photographer, lived in North Aceh was admitted to the ED of Cut Meutia Hospital. He was admitted with worsening dyspnea since 2 days before, initiated after a periode of fever. He also complained of fatigue, palpitations in ordinary activities and chest pain occasionally. He had history of presyncope and syncope. He denied any history of hypertension, type 2 diabetes, allergies, and active smoking. He had no congenital or family history of heart disease. Physical examination revealed full of conciousness with slightly abnormal vital sign. He had malar rash, dilated jugular vein. The apex of the heart shifts to the axilla anterior line, S1>S2 with systolic murmur (+). ECG showed complete RBBB with RAD and chest x-ray showed cardiomegaly. The transthoracic echocardiogram revealed severe TR (Tricuspid Regurgitation), dilatation of RARV (Right Atrium Right Ventricle), with severe PH (Pulmonary Hypertension). The patient was diagnosed with RHF (Right Heart Failure) caused by primary PH. The patient was placed on intravenous furosemide, spironolacton, digoxin, and sildenafil. Treatment and lifestyle modification were expected to improve the quality of life.
Fulltext View|Download
Keywords: pulmonary hypertension; right heart failure

Article Metrics:

  1. Konstam MA, Kiernan MS, Bernstein D, Bozkurt B, Jacob M, Kapur NK, et al. Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association. Vol. 137, Circulation. 2018. 578–622 p
  2. European Society of Cardiology. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. European Heart Journal. 2016;
  3. Hoeper MM, Bogaard HJ. Definitions and Diagnosis of Pulmonary Hypertension. Journal of American College of Cardiology. 2013;
  4. Tello K, Seeger W, Naeije R. Right heart failure in pulmonary hypertension: Diagnosis and new perspectives on vascular and direct right ventricular treatment. British Journal of Pharmacology. 2019;178
  5. Noordegraaf AV, Chin KM, Haddad F. Pathophysiology of the right ventricle and of the pulmonary circulation in pulmonary hypertension: an update. European Resipiratory Journal. 2019;
  6. Zelt JGE, Chaudhary KR, Cadete VJ, Mielniczuk LM, Stewart DJ. Medical Therapy for Heart Failure Associated with Pulmonary Hypertension. Circulation Research. 2019;124(11):1551–67
  7. Zipes DP, Libby P, Bonow RO, Mann DL, Tomaselll GF. Braunwald’s Heart Disease. 11th ed. Philadelphia: Elsevier; 2018
  8. Fuster V, Harrington RA, Narula J, Eapen ZJ. Hurst’s The Heart. 14th ed. United States of America: Mc Graw Hill; 2017
  9. Hashmi MF, Modi P, Sharma S. Dispnea. revised. Treasure Island: StatPearls; 22AD
  10. Maddury J. Cardinal Symptoms of Cardiovascular Diseases: Dyspnea. Indian Journal of Cardiovascular Disease in Women WINCARS. 2018;03(01):039–48
  11. Albakri A. Right heart failure: A review of clinical status and meta-analysis of diagnosis and clinical management methods. Internal Medicine and Care. 2018;2(2)
  12. Sysol JR, Machado RF, F Machado CR. Classification and pathophysiology of pulmonary hypertension. Continuing Cardiology Education 2018 Jun;4(1):2–12
  13. Arrigo M, Huber LC, Winnik S, Mikulicic F, Guidetti F, Frank M, et al. Right Ventricular Failure: Pathophysiology, Diagnosis and Treatment. Cardiac Failure Review. 2019 Nov;5(3):140
  14. Humbert M, Guignabert C, Bonnet S, Dorfmüller P, Klinger JR, Nicolls MR, et al. Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives. The European respiratory journal. 2019 Jan;53(1)
  15. Mukerji V. Dyspnea, Orthopnea, and Paroxysmal Nocturnal Dyspnea. Clinical Methods: The History, Physical, and Laboratory Examinations. 2017;
  16. Stewart S, Carrington MJ, Sliwa K. Rheumatic Heart Disease. Heart of Africa: Clinical Profile of an Evolving Burden of Heart Disease in Africa. 2021 Jul;121–35
  17. Kuhn A, Landmann A. Systemic Lupus Erythematosus. European Handbook of Dermatological Treatments, Third Edition. 2022 Mar;547–60
  18. Ni’am U, Sobirin A, Ropyanto CB. Monitoring Vena Jugularis Presure (JVP) on Heart Disease Patients : Concept Analysis. Journal of TSCNers. 2020;5(1):2503–2453
  19. Hariyono. Buku Ajar Sistem Cardiovaskular. Jombang: ICME PRESS; 2020. 1–126 p
  20. Masola ABCP, Panda AL, Kawengian V. Hubungan gagal jantung dan gangguan fungsi hati. Jurnal e-Clinic (eCl). 2016;4(2)
  21. Simanullang M. GAMBARAN C – reaktive protein (CRP). 2018;7(2):44–68
  22. Indrati AR. Peranan High Sensitivity C-Reactive Protein (hs-CRP) pada Penyakit Jantung Koroner. 2015;6
  23. Fusvita A, Susanti. Gambaran Pemeriksaan Anti Streptolisin O (ASTO) pada Penderita Penyakit Jantung di Rsud Kota Kendari. Jurnal Analis Kesehatan Kendari. 2017;2(1):80–5
  24. Perhimpunan Dokter Spesialis Kardiovaskular Indonesia. Pedoman Diagnosis dan Tatalaksana Hipertensi Pulmonal. 2021
  25. Astuti DPT. Gagal Jantung. Fakultas Kedokteran Universitas Udayana. Denpasar; 2017. p. 1513
  26. Aritonang, Anggraini Y, Leniwita H. Buku I : Medikal Bedah I. Universitas Kristen Indonesia Institutional Repository. 2020;344
  27. Lin W, Poh AL, Tang WHW. Novel Insights and Treatment Strategies for Right Heart Failure. Current Heart Failure Reports. 2018;15(3):141–55
  28. Tilea I, Varga A, Georgescu A-M, Grigorescu B-L. Critical Care Management of Decompensated Right Heart Failure in Pulmonary Arterial Hypertension Patients – An Ongoing Approach. The Journal of Critical Care Medicine. 2021;7(3):170–83
  29. Cassady S, Ramani G V. Right Heart Failure in Pulmonary Hypertension. Cardiology Clinics. 2020;38(2):243–55
  30. Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC/ERS Guidelines for the diagnosis and Treatment of Pulmonary Hypertension. European Respiratory Journal. 2015;46(4):903–75
  31. Hansen L, Burks M, Kingman M, Stewart T. Volume Management in Pulmonary Arterial Hypertension Patients: An Expert Pulmonary Hypertension Clinician Perspective. Pulmonary Therapy. 2018;4(1):13–27
  32. Krowl L, Anjum F, Kaul P. Pulmonary Idiopathic Hypertension. StatPearls - NCBI Bookshelf. 2022
  33. Pandey A, Garg S, Khunger M, Garg S, Kumbhani DJ, Chin KM, et al. Efficacy and Safety of Exercise Training in Chronic Pulmonary Hypertension: Systematic Review and Meta-Analysis. Circulation: Heart Failure. 2015;8(6):1032–43
  34. Fukuda K, Date H, Doi S, Fukumoto Y, Fukushima N, Hatano M, et al. Guidelines for the Treatment of Pulmonary Hypertension (JCS 2017/JPCPHS 2017). Circulation Journal. 2019;83(4):842–945

Last update:

No citation recorded.

Last update:

No citation recorded.